Order Article Reprints

Kim J-H, Jung JH, Lee H-J, Sim D-Y, Im E, Park J, Park W-Y, Ahn C-H, Shim B-S, Kim B, et al. UBE2M Drives Hepatocellular Cancer Progression as a p53 Negative Regulator by Binding to MDM2 and Ribosomal Protein L11. Cancers. 2021; 13(19):4901. https://doi.org/10.3390/cancers13194901

Kim, Ju-Ha, Ji Hoon Jung, Hyo-Jung Lee, Deok-Yong Sim, Eunji Im, Jieon Park, Woon-Yi Park, Chi-Hoon Ahn, Bum-Sang Shim, Bonglee Kim, and et al. 2021. "UBE2M Drives Hepatocellular Cancer Progression as a p53 Negative Regulator by Binding to MDM2 and Ribosomal Protein L11" Cancers 13, no. 19: 4901. https://doi.org/10.3390/cancers13194901

Kim, J.-H., Jung, J. H., Lee, H.-J., Sim, D.-Y., Im, E., Park, J., Park, W.-Y., Ahn, C.-H., Shim, B.-S., Kim, B., & Kim, S.-H. (2021). UBE2M Drives Hepatocellular Cancer Progression as a p53 Negative Regulator by Binding to MDM2 and Ribosomal Protein L11. Cancers, 13(19), 4901. https://doi.org/10.3390/cancers13194901